Article ; Online: Melanoma and eruptive naevi during cetuximab treatment: epidermal growth factor inhibitors and a common concern.
Clinical and experimental dermatology
2021 Volume 46, Issue 8, Page(s) 1584–1586
MeSH term(s) | Antineoplastic Agents, Immunological/adverse effects ; Cetuximab/adverse effects ; Colorectal Neoplasms/drug therapy ; Epidermal Growth Factor/adverse effects ; ErbB Receptors/antagonists & inhibitors ; Humans ; Male ; Melanoma ; Middle Aged ; Nevus, Pigmented/chemically induced ; Skin Neoplasms/chemically induced |
---|---|
Chemical Substances | Antineoplastic Agents, Immunological ; epidermal growth inhibitors ; Epidermal Growth Factor (62229-50-9) ; ErbB Receptors (EC 2.7.10.1) ; Cetuximab (PQX0D8J21J) |
Language | English |
Publishing date | 2021-06-24 |
Publishing country | England |
Document type | Case Reports ; Letter |
ZDB-ID | 195504-4 |
ISSN | 1365-2230 ; 0307-6938 |
ISSN (online) | 1365-2230 |
ISSN | 0307-6938 |
DOI | 10.1111/ced.14787 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1278: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.